FDA approves Monjuvi for relapsed, refractory follicular lymphoma
The U.S. Food and Drug Administration has approved Monjuvi (tafasitamab-cxix) for the treatment of adult patients with relapsed or refractory follicular lymphoma.
Read More
Dual-targeting radiopharmaceutical therapy safe and effective across multiple cancers
A new cancer treatment that delivers radiation directly to tumors by targeting two key markers simultaneously has been shown to be safe and effective in human trials. Acting like a “smart missile,” the dual-targeting radiopharmaceutical is designed to attach to two vulnerable sites on cancer cells, enabling more precise and potent therapy. Early results show that nearly 90% of patients experienced either tumor shrinkage or disease stabilization. These findings were presented at the Society of Nuclear Medicine and Molecular Imaging 2025 Annual Meeting.
New PET tracer delivers high-quality images of brain inflammation activity
A newly developed PET radiotracer has shown the ability to produce high-quality images of real-time brain inflammation, according to research presented at the Society of Nuclear Medicine and Molecular Imaging 2025 Annual Meeting and published as a supplement in the Journal of Nuclear Medicine.
PET imaging links brain inflammation to speech disorder and Parkinson-like syndrome
A novel PET imaging approach has revealed distinct patterns of brain inflammation in patients with progressive apraxia of speech (PAOS), a rare neurodegenerative disorder that affects speech planning. These findings provide new insight into how neuroinflammation and tau pathology may drive disease progression in PAOS, opening potential avenues for earlier diagnosis and targeted treatments.
Hydrops MRI accurately differentiates Meniere disease and vestibular migraine
The combination of cochlear endolymphatic hydrops (CEH) and vestibular endolymphatic hydrops (VEH) on magnetic resonance imaging (MRI) accurately diagnoses Meniere disease (MD) and vestibular migraine (VM), according to a study published online May 13 in Frontiers in Neurology.
Trader Joe’s recalls garlic cheese curds due to listeria risk
A cheese sold at Trader Joe’s has been recalled due to listeria contamination.
Deep sleep and daytime control key to nocturnal enuresis management, finds study
Specific factors, including deep sleep and daytime urinary control, are associated with treatment-responsive nocturnal enuresis among children, according to a study published online April 23 in BMC Pediatrics.
How to identify a victim of heat exhaustion or heat stroke
A powerful heat dome is trapping scorching air and humidity across the Eastern U.S., bringing life‑threatening conditions through midweek.
Ecnoglutide yields superior, sustained reduction in body weight: Study
For adults with obesity or overweight without diabetes, the novel cyclic adenosine monophosphate-biased glucagon-like peptide 1 receptor agonist known as ecnoglutide yields a superior and sustained reduction in body weight versus placebo, according to a study published online June 21 in The Lancet Diabetes & Endocrinology to coincide with the annual meeting of the American Diabetes Association, held from June 20 to 23 in Chicago.
Capsular tension ring implantation linked to improved intraocular lens stability
Capsular tension ring (CTR) implantation is associated with improved stability of the intraocular lens (IOL), according to a review published online June 12 in JAMA Ophthalmology.